Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) Total Current Liabilities (2016 - 2023)

Item 9 Labs' Total Current Liabilities history spans 13 years, with the latest figure at $58.8 million for Q2 2023.

  • For Q2 2023, Total Current Liabilities rose 49.01% year-over-year to $58.8 million; the TTM value through Jun 2023 reached $58.8 million, up 49.01%, while the annual FY2022 figure was $40.6 million, 170.75% up from the prior year.
  • Total Current Liabilities reached $58.8 million in Q2 2023 per INLB's latest filing, up from $47.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $58.8 million in Q2 2023 to a low of $2.7 million in Q2 2019.
  • Average Total Current Liabilities over 5 years is $23.1 million, with a median of $13.6 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: surged 627.45% in 2019, then rose 16.73% in 2020.
  • A 5-year view of Total Current Liabilities shows it stood at $8.9 million in 2019, then grew by 16.73% to $10.4 million in 2020, then surged by 51.49% to $15.7 million in 2021, then skyrocketed by 195.93% to $46.6 million in 2022, then increased by 26.28% to $58.8 million in 2023.
  • Per Business Quant, the three most recent readings for INLB's Total Current Liabilities are $58.8 million (Q2 2023), $47.1 million (Q1 2023), and $46.6 million (Q4 2022).